Artificial intelligence for telemedicine diabetic retinopathy screening: a review.
Luis Filipe NakayamaLucas Zago RibeiroFrederico NovaesIsabele Ayumi MiyawakiAndresa Emy MiyawakiJuliana Angélica Estevão OliveiraTalita Virgínia Fernandes de OliveiraFernando Korn MalerbiCaio Vinicius Saito RegatieriLeo Anthony CeliPaolo S SilvaPublished in: Annals of medicine (2023)
Telemedicine and AI hold great promise for augmenting decision-making in medical care, expanding patient access and enhancing cost-effectiveness. Economic studies and social science analysis are crucial to support the implementation of AI in teleophthalmology screening programs. Promoting fairness and generalizability in automated systems combined with telemedicine screening programs is not straightforward. Improving data representativeness, reducing biases and promoting equity in deployment and post-deployment studies are all critical steps in model development.